Anticoagulation during extracorporeal circulation under conditions of an ongoing systemic inflammatory response syndrome: Effects of heparin

Perfusion

Volumn 20, Issue 1, 2005, Pages 11-15

  Feindt, Peter ^a   Litmathe, Jens ^a   Boeken, Udo ^a   Gams, Emmeran ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; FIBRINOGEN; HEPARIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANESTHESIA INDUCTION; ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRACORPOREAL CIRCULATION; FEMALE; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; LEUKOCYTE COUNT; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT;

AGED; ANTICOAGULANTS; BLOOD COAGULATION; C-REACTIVE PROTEIN; CALCITONIN; CARDIOPULMONARY BYPASS; EXTRACORPOREAL CIRCULATION; FEMALE; HEPARIN; HUMANS; INFLAMMATION; INTERLEUKINS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14544306470     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659105pf776oa     Document Type: Article

References (15)

1. Colman RW. Factor XII activation and inhibition in inflammation. Am J Pathol 1998; 130: 418-26.
2. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676-92.
3. Nieman G, Searles B, Carney D et al. Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment. J Extra Corpor Technol 1999; 31: 202-10.
4. Prondzinsky R, Muller-Werdan U, Pilz G. Systemic inflammatory reactions to extracorporeal therapy measures (II): cardiopulmonary bypass. Wien Klin Wochenschr 1997; 109: 346-53.
5. Grover FL. The society of thoracic surgeons national database: current status and future directions. Ann Thorac Surg 1999; 68: 367-73.
6. Kollef MH, Wragge T, Pasque C. Determinants of mortality and multi organ dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. Chest 1995; 107: 1395-401.
7. Boyle EM, Pohlman TH, Johnsen MC, Verrier ED. The systemic inflammatory response. Ann Thorac Surg 1997; 64: 31-37.
8. Cremer J, Martin M, Redl H, Bahrami S. Systemic inflammatory response syndrome after cardiac operation. Ann Thorac Surg 1996; 61: 1714-20.
9. Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998; 66: 12-16.
10. Hill GE. The inflammatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 104: 1276-80.
11. Burman JF, Chung HI, Lane DA et al. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet 1994; 344: 1192-93.
12. Esmon CT, Fukudome K, Mather T et al. Inflammation, sepsis and coagulation. Hematologica 1999; 84: 254-59.
13. Chandler WL, Fitch JC, Wall MH et al. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost 1995; 74: 1293-97.
14. McGilvray OD, Rotstein OD. Role of the coagulation system in local and systemic inflammatory response. World J Surg 1998; 22 179-86.
15. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery. Implications for the anesthesiologist. Anesthesiology 2002; 97: 215-52.